IL135581A0 - Novel use of compounds for anti-pruritic activity - Google Patents

Novel use of compounds for anti-pruritic activity

Info

Publication number
IL135581A0
IL135581A0 IL13558198A IL13558198A IL135581A0 IL 135581 A0 IL135581 A0 IL 135581A0 IL 13558198 A IL13558198 A IL 13558198A IL 13558198 A IL13558198 A IL 13558198A IL 135581 A0 IL135581 A0 IL 135581A0
Authority
IL
Israel
Prior art keywords
compounds
novel use
pruritic activity
pruritic
activity
Prior art date
Application number
IL13558198A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL135581A0 publication Critical patent/IL135581A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13558198A 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity IL135581A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6374697P 1997-10-17 1997-10-17
PCT/US1998/021886 WO1999020280A1 (en) 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity

Publications (1)

Publication Number Publication Date
IL135581A0 true IL135581A0 (en) 2001-05-20

Family

ID=22051225

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13558198A IL135581A0 (en) 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity

Country Status (18)

Country Link
EP (1) EP1030666A4 (pt)
JP (1) JP2001520196A (pt)
KR (1) KR20010031149A (pt)
CN (1) CN1306426A (pt)
AR (1) AR015966A1 (pt)
AU (1) AU740875B2 (pt)
BR (1) BR9814080A (pt)
CA (1) CA2306985A1 (pt)
CO (1) CO4810374A1 (pt)
CZ (1) CZ20001376A3 (pt)
HU (1) HUP0003792A3 (pt)
IL (1) IL135581A0 (pt)
NO (1) NO20001847L (pt)
NZ (1) NZ503551A (pt)
PL (1) PL341062A1 (pt)
TR (1) TR200001040T2 (pt)
WO (1) WO1999020280A1 (pt)
ZA (1) ZA989450B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL156412A0 (en) 2001-01-31 2004-01-04 Pfizer Prod Inc Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
CN1527830A (zh) 2001-01-31 2004-09-08 �Ʒ� 用作pde4同工酶的抑制剂的醚衍生物
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
KR20030074761A (ko) 2001-01-31 2003-09-19 화이자 프로덕츠 인크. Ｐｄｅ４ 이소자임의 억제제로 유용한 니코틴아미드비아릴 유도체
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
TW200503709A (en) * 2003-07-17 2005-02-01 Santen Pharmaceutical Co Ltd Itching treating agent containing piperidine derivative as active ingredient
JP2005187458A (ja) * 2003-12-04 2005-07-14 Santen Pharmaceut Co Ltd シロミラストまたはその塩を有効成分とする掻痒治療剤
WO2005053672A1 (ja) * 2003-12-04 2005-06-16 Santen Pharmaceutical Co., Ltd. シロミラストまたはその塩を有効成分とする掻痒治療剤
CN101103030B (zh) * 2004-02-14 2010-10-13 史密丝克莱恩比彻姆公司 具有hm74a受体活性的药物
JP2008137892A (ja) * 2005-03-04 2008-06-19 Eisai Co Ltd 止痒剤
BRPI0614270A2 (pt) 2005-08-10 2011-03-22 Smithkline Beecham Corp derivados xantina como seletivos agonistas de ha74a
TWI404709B (zh) * 2006-02-21 2013-08-11 Eisai R&D Man Co Ltd 4- (3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
WO2007097317A1 (ja) * 2006-02-21 2007-08-30 Eisai R & D Management Co., Ltd. ４－（３－ベンゾイルアミノフェニル）－６，７－ジメトキシ－２－メチルアミノキナゾリン誘導体
CA2678477A1 (en) 2007-02-16 2008-08-21 Eisai R&D Management Co., Ltd. Crystal, amorphous form and salt of methyl n-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid
KR20100042246A (ko) 2007-08-17 2010-04-23 에자이 알앤드디 매니지먼트 가부시키가이샤 신규 외용제
CN102532041A (zh) 2007-08-17 2012-07-04 卫材R&D管理有限公司 喹唑啉衍生物的制造方法
JP5985475B2 (ja) * 2011-06-28 2016-09-06 田辺三菱製薬株式会社 新規医薬組成物
MX2017009853A (es) 2015-01-30 2017-11-01 Shanton Pharma Co Ltd Prevencion o tratamiento de enfermedades urinarias o gotosas.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06504534A (ja) * 1990-12-21 1994-05-26 ビーチャム・グループ・パブリック・リミテッド・カンパニー キサンチン誘導体
JP4141501B2 (ja) * 1996-03-26 2008-08-27 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規の６位置換フェナントリジン
US6020340A (en) * 1996-05-15 2000-02-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazopyridines
ES2206909T3 (es) * 1997-03-07 2004-05-16 Altana Pharma Ag Derivados de tetrazol.
CA2282845A1 (en) * 1997-03-18 1998-09-24 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids
JP2002502403A (ja) * 1997-06-03 2002-01-22 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング ベンゾナフチリジン

Also Published As

Publication number Publication date
EP1030666A4 (en) 2002-10-16
WO1999020280A1 (en) 1999-04-29
CO4810374A1 (es) 1999-06-30
BR9814080A (pt) 2000-09-26
HUP0003792A2 (hu) 2001-10-28
AR015966A1 (es) 2001-05-30
CZ20001376A3 (cs) 2002-06-12
NO20001847D0 (no) 2000-04-10
HUP0003792A3 (en) 2001-12-28
AU1093899A (en) 1999-05-10
EP1030666A1 (en) 2000-08-30
KR20010031149A (ko) 2001-04-16
TR200001040T2 (tr) 2001-01-22
CA2306985A1 (en) 1999-04-29
NZ503551A (en) 2002-05-31
CN1306426A (zh) 2001-08-01
AU740875B2 (en) 2001-11-15
NO20001847L (no) 2000-04-10
ZA989450B (en) 1999-04-19
JP2001520196A (ja) 2001-10-30
PL341062A1 (en) 2001-03-26

Similar Documents

Publication Publication Date Title
HK1025322A1 (en) Novel spiroazabicyclic heterocyclic compounds
ZA989450B (en) Novel use of compounds for anti-pruritic activity
EG24041A (en) New heterocyclic compounds
EG24177A (en) Novel compounds
CZ219999A3 (cs) Nové sloučeniny s analgetickým účinkem
PL340400A1 (en) 2-phenyl-substituted imidazotriazinones as inhibitors of phosphodiesterase
IL132170A0 (en) Novel heterocyclic compounds
CZ220099A3 (cs) Nové sloučeniny s analgetickým účinkem
PL337738A1 (en) Novel substituted compounds of imidazole
GB9706255D0 (en) Novel compounds
PL338791A1 (en) Compounds exhibiting neuronic activity
IL113248A0 (en) Use of alpha - 1c specific compounds
IL125840A0 (en) Production of bromine compounds
PL327732A1 (en) Compounds of therapeutic activity
GB9701674D0 (en) Use of organic compounds
ZA981920B (en) Novel heterocyclic compounds
HU9800373D0 (en) Steroide compounds of anticeptive and antiosteoporosive activity
PL327538A1 (en) Novel compounds of analgesic activity
PL339673A1 (en) Novel compounds suitable for use as neuroprotective agents
ZA985448B (en) Novel heterocyclic compounds
HU9700442D0 (en) Compounds of pharmaceutical activity
ZA983800B (en) Novel heterocyclic compounds
AUPP059897A0 (en) New use of bicozamycin
GB9703492D0 (en) Novel compounds
GB9722026D0 (en) Use of compounds